Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Affect Disord. 2020 May 24;274:464–470. doi: 10.1016/j.jad.2020.05.092

Figure 2. Between-group differences in GMV changes after three months of memantine treatment.

Figure 2.

GMV (top panel) and cortical thickness (bottom panel) in the left inferior and middle temporal lobe and the right medial (and for GMV also the lateral OFC) cortices increased significantly more in the memantine compared to the placebo group.